Curiva is headquartered in Goshen, Indiana and has been in operation for 4 years
Curiva is committed to reducing the incidence of cervical cancer by delivering faster, more accurate results through a non-invasive diagnostic patch. Our patient-centric products deliver accurate, same-day results while reducing diagnostic costs for healthcare providers.
A microneedle mediated diagnostic patch, diaPatch™, that detects the early onset of cervical cancer, replacing invasive procedures such as the Pap smear and colposcopy. The digitized medical device is able to detect novel targets within 30-45 min. - equivalent to a clinical visit. Overall, diaPatchTM will provide benefits to healthcare professionals for better management of guidelines and improved patient outcomes.